Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after γ-irradiation through...

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• SWI/SNF chromatin remodeling complexes are crucial for transcription and frequently mutated in human cancers.
• Bcl11b is a SWI/SNF subunit functioning as a tumor suppressor in lymphoid malignancies.
• Its role in solid tumors, particularly intestinal cancers, remains largely unexplored.

Purpose of the Study:

• To investigate the role of Bcl11b in intestinal homeostasis and tumorigenesis.
• To determine the impact of Bcl11b attenuation on intestinal stem cell function and regeneration.
• To elucidate the molecular mechanisms linking Bcl11b to intestinal cancer, focusing on the beta-catenin pathway.

Main Methods:

• Utilized Apc (min/+) mouse models to study intestinal tumorigenesis with altered Bcl11b expression.
• Examined Bcl11b expression in intestinal crypt cells and Lgr5+ stem cells.
• Analyzed human colon cancer samples for BCL11B mutations or allelic loss.
• Assessed the effects of Bcl11b manipulation on beta-catenin target gene expression in vitro and in vivo.

Main Results:

• Bcl11b is expressed in intestinal crypt cells and its attenuation promotes intestinal tumor growth in Apc (min/+) mice.
• Mutations or loss of BCL11B were identified in approximately one-third of human colon cancers.
• Reduced Bcl11b activity in Lgr5+ stem cells enhanced intestinal epithelial regeneration post-radiation injury.
• BCL11B introduction downregulated beta-catenin target genes, while Bcl11b attenuation upregulated targets like c-Myc and cyclin D1.

Conclusions:

• Bcl11b functions as a tumor suppressor in the intestinal epithelium.
• Bcl11b impairment contributes to intestinal tumorigenesis, at least partly, via dysregulation of the beta-catenin pathway.
• Targeting Bcl11b or the beta-catenin pathway may offer therapeutic strategies for colon cancer.